In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device

In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device

A proof-of-concept study of a prototype CloudCath device designed to detect peritonitis using the effluent dialysate from patients undergoing peritoneal dialysis.

Inclusion Criteria:

• Males or females with end-stage renal disease on peritoneal dialysis for a minimum of 10 days prior to obtaining the specimen.
• Specimens shall be leftover (or remnant) from a specimen that has been drained as part of the routine care for the patient.
• Specimens shall not contain any individually identifiable information from the patient it was obtained from.

Exclusion Criteria:

• Patients providing specimens should not be under the administration of any antibiotics other than those utilized for the treatment of peritonitis.
• Patients providing specimens should not suffer from a known liver disease or from ovarian or liver cancer.
• Patients providing specimens should not be under the administration of calcium channel blockers or amlodipine for less than 30 days prior to providing a specimen.